FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Aina Yuan

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Gerald L DeNardo; Saphon Hok; Arutselvan Van Natarajan; Monique Cosman; Sally J DeNardo; Felice C Lightstone; Gary R Mirick; Aina Yuan; Julie Perkins; Vladimir V Sysko; Joerg Lehmann; Rod Balhorn
Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma.
Christine L Hartmann Siantar; Gerald L DeNardo; Kit S Lam; Aina Yuan; Thomas P Daly; Sally J DeNardo
Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissues.
Joerg Lehmann; Gerald L DeNardo; Aina Yuan; Sui Shen; Robert T O'Donnell; Carol M Richman; Sally J DeNardo
Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Aina Yuan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Gerald L DeNardo; Saphon Hok; Arutselvan Van Natarajan; Monique Cosman; Sally J DeNardo; Felice C Lightstone; Gary R Mirick; Aina Yuan; Julie Perkins; Vladimir V Sysko; Joerg Lehmann; Rod Balhorn
Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma.
International journal of oncology 2007;31(4):729-40.
2007: Christine L Hartmann Siantar; Gerald L DeNardo; Kit S Lam; Aina Yuan; Thomas P Daly; Sally J DeNardo
Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissues.
Cancer biotherapy & radiopharmaceuticals 2007;22(4):556-63.
2006: Joerg Lehmann; Gerald L DeNardo; Aina Yuan; Sui Shen; Robert T O'Donnell; Carol M Richman; Sally J DeNardo
Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.
International journal of radiation oncology, biology, physics 2006;66(4):1192-8.
2005: Sui Shen; Gerald L DeNardo; Aina Yuan; Christine Hartmann Siantar; Robert T O'Donnell; Sally J DeNardo
Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody.
Cancer biotherapy & radiopharmaceuticals 2005;20(6):662-70.
2005: Sally J DeNardo; Carol M Richman; Huguette Albrecht; Patricia A Burke; Arutselvan Natarajan; Aina Yuan; Jeffrey P Gregg; Robert T O'Donnell; Gerald L DeNardo
Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7187s-7194s.
2005: Laird A Miers; Kathleen R Lamborn; Aina Yuan; Carol M Richman; Arutselvan Natarajan; Sally J DeNardo; Gerald L DeNardo
Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7158s-7163s.
2005: Carol M Richman; Sally J DeNardo; Robert T O'Donnell; Aina Yuan; Sui Shen; Desiree S Goldstein; Joseph M Tuscano; Ted Wun; Helen K Chew; Primo Lara; David L Kukis; Arutselvan Natarajan; Claude F Meares; Kathleen R Lamborn; Gerald L DeNardo
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5920-7.
2005: Sui Shen; Sally J DeNardo; Carol M Richman; Aina Yuan; Christine Hartmann Siantar; Robert T O'Donnell; Linda A Kroger; Gerald L DeNardo
Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):1034-41.
2003: Sally J DeNardo; Gerald L DeNardo; Aina Yuan; Carol M Richman; Robert T O'Donnell; Primo Lara; David L Kukis; Arutselvan Natarajan; Kathleen R Lamborn; Frederik Jacobs; Christine L Hartmann Siantar
Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3938S-44S.
2003: Gerald L DeNardo; Aina Yuan; Desiree Goldstein; Carol M Richman; Robert T O'Donnell; Sui Shen; Christine Hartmann Siantar; Sally J DeNardo
Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs.
Cancer biotherapy & radiopharmaceuticals 2003;18(2):231-7.
2003: Marie-Anne Descalle; Christine Hartmann Siantar; Lucile Dauffy; David W Nigg; Charles A Wemple; Aina Yuan; Gerald L DeNardo
Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy.
Cancer biotherapy & radiopharmaceuticals 2003;18(1):71-9.
2001: Robert T O'Donnell; Sally J DeNardo; Aina Yuan; Sui Shen; Carol M Richman; Primo Lara; I J Griffith; Desiree S Goldstein; David L Kukis; G S Martinez; Gary R Mirick; Gerald L DeNardo; Frederick J Meyers
Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1561-8.
2000: Gerald L DeNardo; Sally J DeNardo; B W Wessels; David L Kukis; N Miyao; Aina Yuan
131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
Cancer biotherapy & radiopharmaceuticals 2000;15(6):547-60.
2000: Gerald L DeNardo; Robert T O'Donnell; Sui Shen; Linda A Kroger; Aina Yuan; Claude F Meares; David L Kukis; Sally J DeNardo
Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):952-8.
1999: Robert T O'Donnell; Gerald L DeNardo; David L Kukis; Kathleen R Lamborn; Sui Shen; Aina Yuan; Desiree S Goldstein; Catherine E. Carr; Gary R Mirick; Sally J DeNardo
A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2014-20.
1999: Robert T O'Donnell; Gerald L DeNardo; David L Kukis; Kathleen R Lamborn; Sui Shen; Aina Yuan; Desiree S Goldstein; Gary R Mirick; Sally J DeNardo
67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3330s-3336s.
1999: Carol M Richman; Sally J DeNardo; Robert T O'Donnell; Desiree S Goldstein; Sui Shen; David L Kukis; Linda A Kroger; Aina Yuan; G R Boniface; I J Griffith; Gerald L DeNardo
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3243s-3248s.
1999: Robert T O'Donnell; BR Leigh; S D Christensen; Desiree S Goldstein; David L Kukis; Sui Shen; Aina Yuan; DA Denardo; Linda A Kroger; Gerald L DeNardo
Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma.
Cancer biotherapy & radiopharmaceuticals 1999;14(3):167-76.
1998: Gerald L DeNardo; Sui Shen; Sally J DeNardo; S Q Liao; Kathleen R Lamborn; DA Denardo; Aina Yuan
Quantification of iodine-131 in tumors using a threshold based on image contrast.
European journal of nuclear medicine 1998;25(5):497-502.
1997: DA Denardo; Gerald L DeNardo; Robert T O'Donnell; S M Lim; Sui Shen; Aina Yuan; Sally J DeNardo
Imaging for improved prediction of myelotoxicity after radioimmunotherapy.
Cancer 1997;80(12 Suppl):2558-66.
1997: Sui Shen; Gerald L DeNardo; Robert T O'Donnell; Aina Yuan; DA Denardo; Sally J DeNardo
Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies.
Cancer 1997;80(12 Suppl):2553-7.
1997: S Lim; Gerald L DeNardo; DA Denardo; Robert T O'Donnell; Aina Yuan; Sally J DeNardo
Prediction of myelotoxicity using semi-quantitative marrow image scores.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(11):1749-53.
1997: S M Lim; Gerald L DeNardo; DA Denardo; Sui Shen; Aina Yuan; Robert T O'Donnell; Sally J DeNardo
Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1374-8.
1997: Sally J DeNardo; Carol M Richman; Desiree S Goldstein; Sui Shen; QA Salako; David L Kukis; Claude F Meares; Aina Yuan; Jeanna Welborn; Gerald L DeNardo
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.
Anticancer research 1997;17(3B):1735-44.
1997: Sui Shen; Gerald L DeNardo; Sally J DeNardo; Aina Yuan; DA Denardo; Kathleen R Lamborn
Reproducibility of operator processing for radiation dosimetry.
Nuclear medicine and biology 1997;24(1):77-83.
1996: DA Denardo; Gerald L DeNardo; Aina Yuan; Sui Shen; Sally J DeNardo; D J Macey; Kathleen R Lamborn; M Mahe; M W Groch; W D Erwin
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(12):1970-5.
1996: Sui Shen; Gerald L DeNardo; Sally J DeNardo; QA Salako; G Morris; D Banks; Aina Yuan; DA Denardo
Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):146-50.
1994: Sui Shen; Gerald L DeNardo; Aina Yuan; DA Denardo; Sally J DeNardo
Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(8):1381-9.
1994: Sally J DeNardo; Gary R Mirick; Linda A Kroger; L F O'Grady; Kent L Erickson; Aina Yuan; Kathleen R Lamborn; I Hellstrom; K E Hellstrom; Gerald L DeNardo
The biologic window for chimeric L6 radioimmunotherapy.
Cancer 1994;73(3 Suppl):1023-32.